Loading
Cases by country, the UK and NHS pathway and other country lenses, and the expert centres with trials on record.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
New Haven, CT · consortium | United States | none recorded | 0 | 2,224 | 28,423 | none recorded | - |
Rochester, NY · cancer center | United States | 0 | 861 | 12,212 | - | ||
Würzburg · cancer center | Germany | none recorded | 0 | 760 | 11,806 | - | |
Leuven · cancer center | Belgium | none recorded | 0 | 343 | 5,732 | - | |
Toulouse · cancer center | France | none recorded | 0 | 232 | 3,172 | - | |
| Italy | none recorded | 0 | 229 | 2,386 | - | ||
Luxembourg · consortium | Luxembourg | none recorded | 0 | not matched | - | - | |
Aurora, ON · consortium | Canada | none recorded | 0 | not matched | - | - | |
Jerusalem · hospital | Israel | none recorded | 0 | not matched | - | - | |
Atlanta, GA · cancer center | United States | 0 | not matched | - | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Newly diagnosed multiple myeloma, transplant-ineligible but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.